Baltimore City Council
File #: 12-0069R    Version: 0 Name: Histiocytosis Awareness Month
Type: City Council Resolution Status: Adopted
File created: 9/24/2012 In control: City Council
On agenda: Final action: 9/24/2012
Enactment #:
Title: Histiocytosis Awareness Month FOR the purpose of observing Histiocytosis Awareness Month in October and giving special recognition to the families and friends who have worked tirelessly to enable the Histiocytosis Association to raise awareness about these diseases, provide educational and support programs, and, importantly, fund peerreviewed research leading to better treatments and a cure.
Sponsors: James B. Kraft, Brandon M. Scott, Bill Henry, Sharon Green Middleton, Nick Mosby, William "Pete" Welch, William H. Cole, IV, Warren Branch, President Young, Rochelle Spector, Helen L. Holton, Edward Reisinger, Mary Pat Clarke, Robert Curran
Indexes: Resolution
Attachments: 1. 12-0069R - Adopted.pdf
* WARNING: THIS IS AN UNOFFICIAL, INTRODUCTORY COPY OF THE BILL.
THE OFFICIAL COPY CONSIDERED BY THE CITY COUNCIL IS THE FIRST READER COPY.
INTRODUCTORY*

CITY OF BALTIMORE
COUNCIL BILL R
(Resolution)

Introduced by: Councilmember Kraft
A RESOLUTION ENTITLED

A COUNCIL RESOLUTION concerning
title
Histiocytosis Awareness Month

FOR the purpose of observing Histiocytosis Awareness Month in October and giving special recognition to the families and friends who have worked tirelessly to enable the Histiocytosis Association to raise awareness about these diseases, provide educational and support programs, and, importantly, fund peerreviewed research leading to better treatments and a cure.
body

Recitals

Histiocytosis Awareness Month is a collaborative effort by the Histiocytosis Association and community citizens across the country. Histiocytic disorders are considered orphan diseases meaning they affect less than 200,000 people per year in the United States. These diseases occur because of the overproduction of a certain cell in the body and wherever these cells accumulate they cause “cancerlike” damage.

Although these diseases are not thought to be a cancer, the pain and suffering of patients can be just as severe as that caused by the more prevalent diseases that receive a high priority for federal research funding. Some patients can experience a single lesion that goes into remission while others may have several sites of involvement that can be chronic, debilitating, and fatal. There is presently no known cure, and therefore the goal of treatment is to cause the disease to go into remission. Increased funding by the National Institutes of Health is crucial ...

Click here for full text